<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Duindam HB</submitter><funding>ZonMw</funding><pagination>100513</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9482799</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25</volume><pubmed_abstract>&lt;h4>Background and objectives&lt;/h4>Long-term cognitive performance data in former critically ill COVID-19 patients are sparse. Current evidence suggests that cognitive decline is related to neuroinflammation, which might be attenuated by COVID-19 related anti-inflammatory therapies. The objective of this prospective cohort study was to study long term cognitive outcomes following severe COVID-19 and the relation to anti-inflammatory therapies.&lt;h4>Methods&lt;/h4>Prospective observational cohort of patients that survived an intensive care unit (ICU) admission due to severe COVID-19. Six months after hospital discharge, we extensively assessed both objective cognitive functioning and subjective cognitive complaints. Furthermore, patients were stratified in cohorts according to their anti-inflamma</pubmed_abstract><journal>Brain, behavior, &amp; immunity - health</journal><pubmed_title>Long-term cognitive performance and its relation to anti-inflammatory therapy in a cohort of survivors of severe COVID-19.</pubmed_title><pmcid>PMC9482799</pmcid><funding_grant_id>90715610</funding_grant_id><pubmed_authors>Kessels RPC</pubmed_authors><pubmed_authors>Pickkers P</pubmed_authors><pubmed_authors>van den Borst B</pubmed_authors><pubmed_authors>Abdo WF</pubmed_authors><pubmed_authors>Duindam HB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long-term cognitive performance and its relation to anti-inflammatory therapy in a cohort of survivors of severe COVID-19.</name><description>&lt;h4>Background and objectives&lt;/h4>Long-term cognitive performance data in former critically ill COVID-19 patients are sparse. Current evidence suggests that cognitive decline is related to neuroinflammation, which might be attenuated by COVID-19 related anti-inflammatory therapies. The objective of this prospective cohort study was to study long term cognitive outcomes following severe COVID-19 and the relation to anti-inflammatory therapies.&lt;h4>Methods&lt;/h4>Prospective observational cohort of patients that survived an intensive care unit (ICU) admission due to severe COVID-19. Six months after hospital discharge, we extensively assessed both objective cognitive functioning and subjective cognitive complaints. Furthermore, patients were stratified in cohorts according to their anti-inflamma</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-27T02:55:06.547Z</modification><creation>2024-10-15T07:24:13.62Z</creation></dates><accession>S-EPMC9482799</accession><cross_references><pubmed>36159208</pubmed><doi>10.1016/j.bbih.2022.100513</doi></cross_references></HashMap>